ciprofloxacin has been researched along with streptomycin in 138 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (1.45) | 18.7374 |
1990's | 19 (13.77) | 18.2507 |
2000's | 39 (28.26) | 29.6817 |
2010's | 61 (44.20) | 24.3611 |
2020's | 17 (12.32) | 2.80 |
Authors | Studies |
---|---|
Duewelhenke, N; Eysel, P; Krut, O | 1 |
Hall, P; Hudock, MP; Leon, A; Liu, L; Morita, CT; Oldfield, E; Puan, KJ; Studer, D; Yang, Y; Yin, F | 1 |
Adams, J; de Oliveira Garcia, D; Doi, Y; Paterson, DL | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Goswami, M; Jawali, N; Mangoli, SH | 1 |
Barth, AL; Castanheira, M; Gales, AC; Nicoletti, AG; Pereira, AS; Pignatari, AC | 1 |
Altanlar, N; Tekiner-Gulbas, B; Temiz-Arpaci, O; Yildiz, I | 1 |
Al-Momani, W; Antunes, NT; Assunção, P; Ayling, RD; Mercier, P; Poveda, JB; Rosales, RS; Tavío, MM | 1 |
Liu, Y; Shi, W; Wang, M; Wu, S; Xu, X; Ye, X; Zhang, Y | 1 |
Bitting, C; Gruppo, V; Johnson, CM; Lenaerts, AJ; Marietta, KS; Orme, IM; Woolhiser, L | 1 |
Petersen, JM; Urich, SK | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Bammert, GF; Banitt, LS; Barbachyn, MR; Boyle, TP; Bundy, GL; Dolak, LA; Ford, CW; Graber, DR; Hamel, JC; Han, F; Harris, DW; Hromockyj, AE; Hurd, AR; Kamilar, GM; Marotti, KR; Martin, GE; Miller, AA; Mott, JE; Munzner, JB; Palmer, JR; Ruble, JC; Seest, EP; Skepner, JE; Sweeney, MT; Zhong, WZ; Zurenko, GE | 1 |
Hansen, S; Lewis, K; Vulić, M | 1 |
Andersson, DI; Negrea, A; Pränting, M; Rhen, M | 1 |
Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
Ike, Y; Inoue, T; Tomita, H; Zheng, B | 1 |
Hosamani, KM; Keri, RS; Shingalapur, RV | 1 |
Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
Jain, R; Reddy, RP; Sharma, RK; Tegge, W | 1 |
Carattoli, A; Ellington, MJ; Karisik, E; Livermore, DM; Underwood, A; Woodford, N | 1 |
Arhin, FF; Draghi, DC; Moeck, G; Parr, TR; Pillar, CM; Sahm, DF | 1 |
Dempsey, S; Jack, C; Miller, CH; Nisa, S; O'Toole, R | 1 |
Ahmed, S; Calderwood, SB; Faruque, AS; Hooper, DC; Jacoby, GA; Khan, WA; Kim, HB; LaRocque, RC; Park, CH; Qadri, F; Salam, MA; Wang, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bunders, C; Huigens, RW; Melander, C; Reed, CS; Reyes, S; Rogers, SA; Steinhauer, AT | 1 |
Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
Bremont, S; Courvalin, P; Hervé-Bazin, M; Le Monnier, A; Leclercq, A; Lecuit, M; Morvan, A; Moubareck, C | 1 |
Mima, T; Schweizer, HP | 1 |
Goswami, M; Jawali, N | 1 |
Bohnert, JA; Karamian, B; Nikaido, H | 1 |
Chen, S; Chen, Z; Deng, Y; Huang, X; Liu, JH; Liu, Y; Sun, Y; Tian, W; Wu, C; Zeng, Z; Zhao, J | 1 |
Abdullah, ST; Ahmed, SK; Azeeza, S; Kamal, A; Khan, IA; Reddy, AM; Sharma, S; Shetti, RV; Swapna, P | 1 |
Bogaerts, P; Buvens, G; Glupczynski, Y; Lauwers, S; Piérard, D | 1 |
Briguglio, I; Carta, A; Corona, P; Guglierame, P; Jabes, D; Molicotti, P; Palomba, M; Piras, S; Zanetti, S | 1 |
Chiba, T; Hasegawa, T; Horita, Y; Kremer, L; Kuroishi, R; Lee, Y; Ogawa, K; Onozaki, K; Sato, Y; Takii, T | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Aggarwal, N; Dureja, P; Khurana, JM; Kumar, R | 1 |
Constant, P; Daffé, M; Massimba Dibama, H; Mourer, M; Regnouf-de-Vains, JB | 1 |
Arun, Y; Balachandran, C; Bhaskar, G; Perumal, PT; Saikumar, C | 1 |
Koyama, N; Takahashi, Y; Tokura, Y; Tomoda, H | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Basireddy, VS; Dharmarajan, S; Guttala, RS; Jagarlamudi, PS; Mukkara, LD; Pagadala, LR; Perumal, Y; Ravirala, N; Singh, A; Singireddi, S; Thummaluru, VR; Ummanni, R; Upadhyayula, SM | 1 |
Bharate, SS; Vishwakarma, RA | 1 |
Constant, P; Daffé, M; Massimba-Dibama, H; Mourer, M; Regnouf-de-Vains, JB | 1 |
Anand, A; Dixit, SR; Joshi, SD; Kulkarni, MV; Naik, RJ; Revankar, HM | 1 |
Dalimba, U; Nayak, N; Ramprasad, J | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Abouelhassan, Y; Bai, F; Burch, GM; Garrison, AT; Huigens, RW; Jin, S; Kallifidas, D; Luesch, H; Nguyen, MT; Norwood, VM; Rolfe, M | 1 |
Chandrasekaran, B; Cherukupalli, S; Hampannavar, GA; Karpoormath, R; Palakollu, VN; Thapliyal, N | 1 |
Balaji, NV; Hari Babu, B; Murali Krishna Kumar, M; Purna Nagasree, K; Subbaraju, GV | 1 |
Desai, S; Desai, V; Dixit, SK; Gaonkar, SN; Joshi, SD; Palyekar, U | 1 |
Dalimba, U; Madan Kumar, S; Reddyrajula, R | 1 |
Bera, S; Mondal, D | 1 |
Anil Kumar, GN; Joshi, SD; Khanapurmath, N; Kulkarni, MV | 1 |
Gao, F; Huang, G; Xiao, J | 1 |
Liu, H; Long, S; Rakesh, KP; Zha, GF | 1 |
Dalimba, U; Reddyrajula, R | 1 |
Bangalore, PK; Bollikanda, RK; Choudante, PC; Kantevari, S; Misra, S; Sridhar, B; Sriram, D; Vagolu, SK; Veeragoni, DK | 1 |
Düzgüneş, N; Flasher, D; Friend, DS; Hadley, WK; Majumdar, S; Nassos, P; Yajko, D | 1 |
Lang, R; Rubinstein, E; Shasha, B | 2 |
Fuursted, K | 1 |
Collins, CH; Uttley, AH | 1 |
Nelson, SD; Nolan, CM; Sandblom, RE; Slattery, JT; Thummel, KE | 1 |
Simonetti, MT; Tortoli, E | 1 |
Ahn, CH; Brown, BA; Dunbar, D; Dunlap, R; Murphy, DT; Onyi, G; Wallace, RJ | 1 |
Mironin, AV; Paramonov, VE; Romanov, VE; Shabalin, BA; Vasil'ev, NT | 1 |
Koga, H; Kohno, S; Miyamoto, J; Ogawa, K; Ohno, H; Tashiro, T; Tomono, K | 1 |
Arana, I; Barcina, I; Fernández-Astorga, A; Muela, A; Pocino, M | 1 |
Fischbarg, J; Kang, F; Kuang, K; Li, J; Serdarevic, ON; Zhu, Z | 1 |
Chen, SN; Lee, KK; Liu, PC | 1 |
Chankova, D; Guirguitzova, B; Minkov, N; Zozikov, B | 1 |
Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
Grudinina, SA; Krotova, LA; Rezvan, SP; Sidorenko, SV; Sterkhova, GV | 1 |
Ansorg, R; Fabry, W; Schmid, EN | 1 |
Efron, A; Lopardo, H; Lucero, NE | 1 |
Delgado, F; Lopez-Gonzalez, MA; Lucas, M | 1 |
Drobniewski, FA; Eltringham, IJ; Wilson, SM | 1 |
Hakola, K; Savola, J | 1 |
Guoming, L; Qun, C; Shengchun, W | 1 |
Bajaksouzian, S; Jacobs, MR; Joloba, ML | 1 |
Araj, GF; Zouain, MG | 1 |
Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Sánchez-Silos, RM | 1 |
Arangie, P; Gilbert-Palmer, D; Payne, WC; Persell, DJ; Skorga, P; Stokes, EN; Young, C | 1 |
de la Campa, AG; Martín-Galiano, AJ | 1 |
Göksoy, EO; Kaya, O; Kirkan, S | 1 |
Nowakowska, M; Radosz-Komoniewska, H; Rudy, M; Wiechuła, B; Zientara, M | 1 |
Baek, DH; Chung, MJ; Ha, NJ; Kang, BY; Kang, JY; Kim, K; Kim, SD; Shin, EA; Yim, DS; Yun, JH | 1 |
Chimara, E; da Silva Telles, MA; Ferrazoli, L; Riley, LW | 1 |
Alp, E; Aygen, B; Doganay, M; Durak, AC; Koc, RK; Sumerkan, B; Yildiz, O | 1 |
Ayoğlu, F; Baruönü, F; Celebi, G; Cinar, F; Gedikoğlu, S; Karadenizli, A; Uğur, MB | 1 |
Durdu, YB; Kutlu, SB; Nazlican, O; Ozdemir, R; Sengöz, G; Yaşar, KK | 1 |
Joo, LM; Macfarlane-Smith, LR; Okeke, IN | 1 |
Cardona, L; Davis, LE; Hofinger, DM; Mertz, GJ | 1 |
Korsak, D; Maćkiw, E; Rzewuska, K | 1 |
Athanasiou, H; Ioannou, S; Karadima, D; Pneumaticos, S; Pontikis, J; Sipsas, NV; Zormpala, A | 1 |
Aathithan, S; French, GL | 1 |
Kacouchia, N; Koffi-N'guessan, L; Kouassi, M; Kouassi-Ndjeundo, J; Mobio, NM; N'gattia, KV; Vroh Bi, TS; Yoda, M | 1 |
Kumar, R; Singh, RS; Yadav, BR | 1 |
Ambrose, PG; Bhavnani, SM; Caws, M; Chau, TT; Dung, NT; Farrar, J; Hammel, JP; Hien, TT; Kulawy, R; Mai, PP; Reynolds, DK; Thwaites, GE; Török, ME; Van Wart, SA | 1 |
Chakraborty, A; Takade, A; Villanueva, SY; Yoshida, S | 1 |
Blair, JL; Clinkenbeard, KD; Ponnusamy, D; Reiber, D; Wendte, JM | 1 |
Gerstrøm, SC; Krogfelt, KA; Petersen, AM; Schjørring, S | 1 |
Chitnis, DS; Hemvani, N; Patidar, V | 2 |
Caramia, G; Ruffini, E | 1 |
Basualdo, J; Bernstein, J; De Luca, M; Delpech, G; Grenovero, S; Pourcel, G; Schell, C; Sparo, M | 1 |
Mehrani, M; Mortaz-Hejri, S; Sadeghipour, P; Yousefi-Nooraie, R | 1 |
Ekin, IH; Ilhan, Z; Solmaz, H | 1 |
Bojarska, A; Gawryszewska, I; Hryniewicz, W; Malinowska, K; Sadowy, E; Sieńko, A | 1 |
Araújo, PA; Melo, L; Mergulhão, F; Simões, M | 1 |
Kaur, S; Sharma, P | 1 |
Clifford, R; Marquart, JD | 1 |
Alves, TM; Barbosa Pauletti, R; de Sousa Moura Souto, M; Heinemann, MB; Lage, AP; Minharro, S; Pinto da Silva Mol, J; Reinato Stynen, AP; Seles Dorneles, EM | 1 |
Dan, LA; Lim, RL; Ngu, DY; Ooi, A; Wong, A | 1 |
Jagannadham, MV; Kulkarni, HM; Nagaraj, R | 1 |
Eakambaram, RS; Ibrahim, IA; Krishnasamy, SK; Mathew, S; Namasivayam, V; Natarajan, A; Palaniappan, S | 1 |
Ali, A; Arora, P; Nalli, Y; Riyaz-Ul-Hassan, S; Wani, ZA | 1 |
Burgos, MJ; Fernández Márquez, ML; Gálvez, A; López, RL; Pulido, RP | 1 |
Clifton, DA; Crook, DW; Iqbal, Z; Niehaus, KE; Peto, TEA; Smith, EG; Walker, AS; Walker, TM; Wilson, DJ; Yang, Y; Zhu, T | 1 |
Andrianaivoarimanana, V; Bertherat, E; Rajaonarison, R; Rajerison, M; Rakotondramaro, T; Rogier, C | 1 |
Aranda-Díaz, A; Fischbach, MA; Frankel, MR; Higginbottom, SK; Huang, KC; Merrill, BD; Neff, NF; Ng, KM; O'Loughlin, CT; Oliveira, RA; Pruss, KM; Sonnenburg, JL; Tropini, C; Van Treuren, W; Xavier, KB; Yu, FB | 1 |
Behzadi, P; Hozzari, A; Kerishchi Khiabani, P; Sabokroo, N; Sholeh, M | 1 |
Cabral, V; Correia, MB; Huang, KC; Ng, KM; Oliveira, RA; Shi, H; Sonnenburg, JL; Xavier, KB | 1 |
Delarampour, A; Ghalehnoo, ZR; Khademi, F; Vaez, H | 1 |
Andrianaivoarimanana, V; Baril, L; Bourner, J; Edwards, T; Gillesen, A; Horby, P; Legrand, A; Mangahasimbola, R; Mayouya-Gamana, T; Olliaro, P; Raberahona, M; Rajerison, M; Randremanana, RV; Randria, MJD; Randriamparany, R; Rasoanaivo, TF; Salam, A; Schoenhals, M | 1 |
Bezmaternykh, KV; Oktyabrsky, ON; Smirnova, GV; Tyulenev, AV | 1 |
Badran, AH; Bening, SC; Cheney, NJ; Collins, JJ; Earl, AM; Kohanski, MA; Lopatkin, AJ; Manson, AL; Stokes, JM; Yang, JH | 1 |
Barnwal, RP; De Rosa, M; Pandey, A; Sharma, A; Singh, G; Singla, N | 1 |
Al-Talhy, AM; Ali, H; Dadar, M; Elkharsawi, AR; Hamdy, MER; Neubauer, H; Tawab, AAAE; Wareth, G | 1 |
Pintarić, S; Štritof, Z; Tumpa, A | 1 |
Chen, H; Dai, L; Hou, D; Li, T; Long, X; Sun, C; Wang, Y; Xiong, Z | 1 |
Mishra, V; Ojha, AK; Shah, NP | 1 |
Abidi, SH; Ahmed, K; Ali, SN; Khan, S; Mastoor, S; Nazim, F; Rizwan-Ul-Hasan, S | 1 |
Chaintoutis, SC; Lazou, TP | 1 |
Call, DR; Grossi, JL; Nero, LA; Yamatogi, RS | 1 |
11 review(s) available for ciprofloxacin and streptomycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.
Topics: Animals; Chemistry Techniques, Synthetic; Humans; Pyrazoles; Pyrimidines | 2017 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents.
Topics: Anti-Bacterial Agents; Antiviral Agents; Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Triazines; Viruses | 2020 |
Preparing for bioterrorism: category A agents.
Topics: Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Bioterrorism; Botulism; Ciprofloxacin; Humans; Plague; Preventive Health Services; Smallpox; Smallpox Vaccine; Streptomycin; Tularemia | 2001 |
Tularemic meningitis in the United States.
Topics: Administration, Oral; Adult; Chloramphenicol; Ciprofloxacin; Diagnosis, Differential; Drug Therapy, Combination; Francisella tularensis; Humans; Infusions, Intravenous; Male; Meningitis; New Mexico; Occupational Diseases; Streptomycin; Tularemia; United States | 2009 |
[Antibiotic resistance of bacteria Campylobacter sp].
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Gentamicins; Humans; Streptomycin; Tetracycline | 2010 |
[Proper antibiotic therapy. From penicillin to pharmacogenomic].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalexin; Chloramphenicol; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Evidence-Based Medicine; Genetic Testing; Genetic Variation; Hospitals; Humans; Microbial Sensitivity Tests; Penicillins; Pharmacogenetics; Practice Patterns, Physicians'; Streptomycin; Tetracyclines | 2012 |
Antibiotics for treating human brucellosis.
Topics: Anti-Bacterial Agents; Brucellosis; Ciprofloxacin; Doxycycline; Humans; Ofloxacin; Randomized Controlled Trials as Topic; Rifampin; Streptomycin | 2012 |
The perspective of antibiotic therapeutic challenges of brucellosis in the Middle East and North African countries: Current situation and therapeutic management.
Topics: Animals; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Chloramphenicol; Ciprofloxacin; Doxycycline; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle East; Ruminants; Streptomycin; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |
3 trial(s) available for ciprofloxacin and streptomycin
Article | Year |
---|---|
Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647].
Topics: Anti-Bacterial Agents; Brucellosis; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Humans; Rifampin; Spine; Spondylitis; Streptomycin | 2006 |
Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Injections, Intramuscular; Isoniazid; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal; Young Adult | 2011 |
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial.
Topics: Ciprofloxacin; Equivalence Trials as Topic; Female; Humans; Madagascar; Male; Plague; Streptomycin; Yersinia pestis | 2020 |
124 other study(ies) available for ciprofloxacin and streptomycin
Article | Year |
---|---|
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.
Topics: Anti-Bacterial Agents; Cluster Analysis; Diphosphonates; Drug Synergism; Escherichia coli K12; Fosfomycin; Gene Expression; Geranyltranstransferase; Models, Molecular; Oligonucleotide Array Sequence Analysis; Quantitative Structure-Activity Relationship; Terpenes | 2006 |
Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil.
Topics: Amino Acid Sequence; Aminoglycosides; beta-Lactamases; Brazil; Carbapenems; Cloning, Molecular; Drug Resistance, Multiple, Bacterial; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Effects of glutathione and ascorbic acid on streptomycin sensitivity of Escherichia coli.
Topics: Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Catalase; Escherichia coli; Glutathione; Indicators and Reagents; Nitroblue Tetrazolium; Peroxidases; Peroxiredoxins; Reactive Oxygen Species; Streptomycin; Superoxide Dismutase | 2007 |
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Integrons; Latin America; Molecular Sequence Data; Plasmids | 2007 |
Synthesis and in vitro antimicrobial activity of new 2-[p-substituted-benzyl]-5-[substituted-carbonylamino]benzoxazoles.
Topics: Amination; Anti-Bacterial Agents; Antifungal Agents; Benzene; Benzoxazoles; Candida; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Structure; Structure-Activity Relationship | 2007 |
In vitro susceptibilities of Mycoplasma putrefaciens field isolates.
Topics: Anti-Bacterial Agents; France; Humans; Jordan; Lincomycin; Macrolides; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma Infections; Tetracycline Resistance | 2007 |
Prevalence and expression of the plasmid-mediated quinolone resistance determinant qnrA1.
Topics: Anti-Infective Agents; Base Sequence; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae; Gene Expression Regulation, Bacterial; Genes, Bacterial; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Evaluation of a 2-pyridone, KRQ-10018, against Mycobacterium tuberculosis in vitro and in vivo.
Topics: Animals; Antitubercular Agents; Biological Availability; Interferon-gamma; Mice; Mice, Inbred C57BL; Mice, Knockout; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyridones; Quinolones; Treatment Outcome; Tuberculosis, Pulmonary | 2008 |
In vitro susceptibility of isolates of Francisella tularensis types A and B from North America.
Topics: Anti-Bacterial Agents; Francisella tularensis; Humans; Microbial Sensitivity Tests; North America; Tularemia | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Line; Cell Proliferation; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors | 2008 |
Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Mutation; Nucleotides; Ofloxacin | 2008 |
Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cathelicidins; Drug Resistance, Multiple, Bacterial; Female; Genetic Complementation Test; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Models, Genetic; Mutagenesis, Insertional; Mutation; Salmonella Infections, Animal; Salmonella typhimurium; Sequence Deletion | 2008 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Bacteriocins; Blotting, Southern; Conjugation, Genetic; Cross Infection; Culture Media; DNA Nucleotidyltransferases; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Erythromycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Perforin; Pheromones; Plasmids; Vancomycin Resistance | 2009 |
Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antitubercular Agents; Bacteria; Benzimidazoles; Fungi; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Structure-Activity Relationship | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Discovery of Trp-His and His-Arg analogues as new structural classes of short antimicrobial peptides.
Topics: Antimicrobial Cationic Peptides; Bacteria; Dipeptides; Drug Discovery; Fungi; Microbial Sensitivity Tests | 2009 |
Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone.
Topics: beta-Lactamases; Computational Biology; Escherichia coli; Models, Genetic; Molecular Sequence Data; Open Reading Frames; Plasmids; United Kingdom | 2009 |
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus | 2009 |
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
Topics: Antitubercular Agents; Cysteine; Drug Evaluation, Preclinical; Mycobacterium; Mycobacterium smegmatis; Organoselenium Compounds; Selenocysteine; Small Molecule Libraries | 2009 |
Transferable quinolone resistance in Vibrio cholerae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chromosomes, Bacterial; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Quinolones; Vibrio cholerae | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Benzimidazoles; Drug Resistance, Multiple, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Conformation; Small Molecule Libraries; Stereoisomerism; Structure-Activity Relationship | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
Antimicrobial resistance of Listeria monocytogenes strains isolated from humans in France.
Topics: Anti-Bacterial Agents; Base Sequence; DNA Primers; Drug Resistance, Bacterial; Evolution, Molecular; France; Gene Transfer, Horizontal; History, 20th Century; History, 21st Century; Humans; In Vitro Techniques; Listeria monocytogenes; Listeriosis; Microbial Sensitivity Tests; Molecular Epidemiology; Time Factors | 2010 |
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Burkholderia pseudomallei; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Periplasmic Proteins; Quorum Sensing; Singapore; Virulence Factors | 2010 |
N-acetylcysteine-mediated modulation of bacterial antibiotic susceptibility.
Topics: Acetylcysteine; Anti-Bacterial Agents; Culture Media; Drug Resistance, Bacterial; Expectorants; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment.
Topics: Animals; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Quinolones | 2010 |
Anti-tubercular agents. Part 5: synthesis and biological evaluation of benzothiadiazine 1,1-dioxide based congeners.
Topics: Animals; Antitubercular Agents; Bacteria; Benzothiadiazines; Cell Line; Cell Survival; Female; Fungi; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis | 2010 |
Antimicrobial resistance testing of verocytotoxin-producing Escherichia coli and first description of TEM-52 extended-spectrum β-lactamase in serogroup O26.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Humans; Plasmids; Shiga Toxins | 2010 |
Synthesis and anti-mycobacterial activities of triazoloquinolones.
Topics: Anti-Bacterial Agents; Candida; Cell Line, Tumor; Humans; Microbial Sensitivity Tests; Mycobacterium; Quinolones | 2011 |
Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.
Topics: Antitubercular Agents; Carbohydrates; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxidoreductases; Thiocarbamates; Thioglucosides | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis, antimicrobial evaluation and QSAR analysis of novel nalidixic acid based 1,2,4-triazole derivatives.
Topics: Anti-Infective Agents; Bacteria; Fungi; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Nalidixic Acid; Quantitative Structure-Activity Relationship; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Triazoles | 2011 |
Anti-mycobacterial activities of some cationic and anionic calix[4]arene derivatives.
Topics: 2,2'-Dipyridyl; Anions; Antitubercular Agents; Calixarenes; Guanidine; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenols; Quaternary Ammonium Compounds; Tuberculosis | 2012 |
Synthesis of novel spirooxindole derivatives by one pot multicomponent reaction and their antimicrobial activity.
Topics: Anti-Infective Agents; Bacteria; Chemistry Techniques, Synthetic; Fungi; Indoles; Microbial Sensitivity Tests; Oxindoles | 2012 |
Discovery of nosokophic acid, a predicted intermediate of moenomycins, from nosokomycin-producing Streptomyces sp. K04-0144.
Topics: Anti-Bacterial Agents; Bambermycins; Drug Discovery; Drug Synergism; Hexuronic Acids; Imipenem; Magnetic Resonance Spectroscopy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Organophosphates; Streptomyces | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Design, synthesis and anti-mycobacterial activity of 1,2,3,5-tetrasubstituted pyrrolyl-N-acetic acid derivatives.
Topics: Acetates; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrroles; Structure-Activity Relationship | 2014 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Guanidinium compounds with sub-micromolar activities against Mycobacterium tuberculosis. Synthesis, characterization and biological evaluations.
Topics: Antitubercular Agents; Guanidine; Humans; Models, Molecular; Mycobacterium tuberculosis; Tuberculosis | 2015 |
A click chemistry approach for the synthesis of mono and bis aryloxy linked coumarinyl triazoles as anti-tubercular agents.
Topics: Antitubercular Agents; Click Chemistry; Coumarins; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship; Triazoles | 2015 |
Design of new phenothiazine-thiadiazole hybrids via molecular hybridization approach for the development of potent antitubercular agents.
Topics: Animals; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Phenothiazines; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship; Thiadiazoles; Vero Cells | 2015 |
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
Topics: Biofilms; Carbon-13 Magnetic Resonance Spectroscopy; Drug Resistance, Bacterial; Drug Screening Assays, Antitumor; Halogens; HeLa Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenazines; Proton Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 2016 |
Synthesis, screening and docking analysis of hispolon analogs as potential antitubercular agents.
Topics: Antitubercular Agents; Catechols; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2017 |
Novel quinoxalinyl chalcone hybrid scaffolds as enoyl ACP reductase inhibitors: Synthesis, molecular docking and biological evaluation.
Topics: Anti-Infective Agents; Antineoplastic Agents; Binding Sites; Candida albicans; Cell Proliferation; Chalcones; Disk Diffusion Antimicrobial Tests; Drug Design; Enoyl-CoA Hydratase; Enzyme Inhibitors; Escherichia coli; Humans; MCF-7 Cells; Molecular Docking Simulation; Mycobacterium tuberculosis; Protein Structure, Tertiary; Staphylococcus aureus | 2017 |
Molecular hybridization approach for phenothiazine incorporated 1,2,3-triazole hybrids as promising antimicrobial agents: Design, synthesis, molecular docking and in silico ADME studies.
Topics: Adsorption; Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Phenothiazines; Pseudomonas aeruginosa; Staphylococcus aureus; Structure-Activity Relationship; Triazoles; Vero Cells | 2019 |
A click chemistry approach for the synthesis of cyclic ureido tethered coumarinyl and 1-aza coumarinyl 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis H37Rv and their in silico studies.
Topics: Algorithms; Antitubercular Agents; Click Chemistry; Coumarins; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles; Uracil | 2019 |
The bioisosteric modification of pyrazinamide derivatives led to potent antitubercular agents: Synthesis via click approach and molecular docking of pyrazine-1,2,3-triazoles.
Topics: Antitubercular Agents; Humans; Molecular Docking Simulation; Molecular Structure; Pyrazinamide; Structure-Activity Relationship; Triazoles | 2020 |
Usnic Acid Enaminone-Coupled 1,2,3-Triazoles as Antibacterial and Antitubercular Agents.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacillus subtilis; Benzofurans; Lichens; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Triazoles | 2020 |
Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages.
Topics: Ciprofloxacin; Drug Carriers; Humans; Liposomes; Macrophages; Monocytes; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Streptomycin | 1992 |
Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin.
Topics: Administration, Oral; Animals; Brucellosis; Ciprofloxacin; Doxycycline; Injections, Intraperitoneal; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Comparative killing activity and postantibiotic effect of streptomycin combined with ampicillin, ciprofloxacin, imipenem, piperacillin or vancomycin against strains of Streptococcus faecalis and Streptococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Imipenem; Piperacillin; Streptococcus; Streptomycin; Thienamycins; Vancomycin | 1988 |
In vitro activity of ciprofloxacin in combination with standard antituberculous drugs against mycobacterium tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Streptomycin | 1988 |
Hepatotoxicity associated with acetaminophen usage in patients receiving multiple drug therapy for tuberculosis.
Topics: Acetaminophen; Adult; Capreomycin; Ciprofloxacin; Drug Combinations; Drug Overdose; Ethambutol; Female; Humans; Isoniazid; Liver; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1994 |
Radiometric susceptibility testing of Mycobacterium xenopi.
Topics: Amikacin; Ciprofloxacin; Ethambutol; Microbial Sensitivity Tests; Nontuberculous Mycobacteria; Radiometry; Rifabutin; Rifampin; Streptomycin | 1995 |
Rifampin-resistant Mycobacterium kansasii.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Ciprofloxacin; Clinical Protocols; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pyrazinamide; Pyridoxine; Rifampin; Streptomycin; Texas; Treatment Outcome; Tuberculosis | 1994 |
Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin.
Topics: Animals; Body Weight; Brucella; Brucellosis; Ciprofloxacin; Colony Count, Microbial; Doxycycline; Drug Synergism; Drug Therapy, Combination; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Organ Size; Rifampin; Spleen; Streptomycin | 1993 |
[Standardization of conditions for the evaluation of effectiveness of antibacterial drugs in pneumonic plague in sacred baboons].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Body Temperature Regulation; Ciprofloxacin; Drug Evaluation, Preclinical; Female; Gentamicins; Lung Diseases; Male; Monkey Diseases; Netilmicin; Papio; Plague; Streptomycin | 1995 |
A rapid drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay.
Topics: Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Colony Count, Microbial; Ethambutol; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nucleic Acid Hybridization; Streptomycin; Time Factors | 1997 |
Detection and enumeration of viable but non-culturable transconjugants of Escherichia coli during the survival of recipient cells in river water.
Topics: Ciprofloxacin; Colony Count, Microbial; Conjugation, Genetic; Escherichia coli; Fresh Water; Kanamycin; Streptomycin | 1997 |
Effects of ciprofloxacin, streptomycin, and gentamicin on rabbit corneal transendothelial electrical potential difference.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biological Transport; Ciprofloxacin; Electric Conductivity; Endothelium, Corneal; Gentamicins; Membrane Potentials; Rabbits; Streptomycin | 1998 |
Susceptibility of different isolates of Vibrio harveyi to antibiotics.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Decapoda; Doxycycline; Drug Resistance, Microbial; Erythromycin; Fish Diseases; Fishes; Microbial Sensitivity Tests; Nalidixic Acid; Nitrofurantoin; Novobiocin; Oxolinic Acid; Oxytetracycline; Penicillins; Seawater; Streptomycin; Sulfonamides; Vancomycin; Vibrio; Vibrio Infections; Water Microbiology | 1997 |
[Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].
Topics: Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriuria; beta-Lactamases; Child; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Penicillin Resistance; Penicillins; Streptomycin; Urinary Tract Infections; Vancomycin | 1998 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
[Multicenter trial of Enterococcus antibiotic susceptibility].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Gentamicins; Microbial Sensitivity Tests; Moscow; Penicillins; Russia; Streptomycin; Sulbactam; Vancomycin | 1998 |
Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Fleroxacin; Fusidic Acid; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Streptomycin | 1995 |
[In vitro sensitivity to five antibiotics of clinical isolated Brucella spp].
Topics: Anti-Bacterial Agents; Brucella; Ciprofloxacin; Doxycycline; Humans; Microbial Sensitivity Tests; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
Aminoglycosides activate oxygen metabolites production in the cochlea of mature and developing rats.
Topics: Aging; Animals; Animals, Newborn; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cochlea; Drug Synergism; Gentamicins; In Vitro Techniques; Rats; Rats, Wistar; Reactive Oxygen Species; Streptomycin; Tetradecanoylphorbol Acetate | 1999 |
Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Drug Resistance, Microbial; Ethambutol; Evaluation Studies as Topic; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacteriophages; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Streptomycin; Tuberculosis | 1999 |
[Meningitis caused by Francisella Tularensis].
Topics: Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Follow-Up Studies; Francisella tularensis; Headache; Humans; Meningitis; Middle Aged; Streptomycin; Tularemia | 1996 |
Resistance of Neisseria gonorrhoeae epidemic strains to antibiotics: report of resistant isolates and surveillance in Zhanjiang, China: 1998 to 1999.
Topics: Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Streptomycin; Tetracycline | 2000 |
Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.
Topics: Agar; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin | 2000 |
Antimicrobial resistance of Enterococci in Lebanon.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Erythromycin; Gentamicins; Humans; Lebanon; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Rifampin; Streptomycin; Teicoplanin; Tetracycline; Vancomycin | 2001 |
Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Incidence; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Spain; Streptomycin; Vancomycin | 2001 |
High-efficiency generation of antibiotic-resistant strains of Streptococcus pneumoniae by PCR and transformation.
Topics: Amino Acid Sequence; Ciprofloxacin; Drug Resistance, Bacterial; Molecular Sequence Data; Polymerase Chain Reaction; Rifampin; Streptococcus pneumoniae; Streptomycin; Transformation, Bacterial | 2003 |
Isolation and antimicrobial susceptibility of Aeromonas salmonicida in rainbow trout (Oncorhynchus mykiss) in turkey hatchery farms.
Topics: Aeromonas; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Fish Diseases; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Oncorhynchus mykiss; Streptomycin; Turkey | 2003 |
[Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins; Poland; Streptomycin; Teicoplanin; Tetracycline; Urinary Tract Infections; Vancomycin | 2004 |
Identification of Lactobacillus ruminus SPM0211 isolated from healthy Koreans and its antimicrobial activity against some pathogens.
Topics: Adult; Base Sequence; Ciprofloxacin; DNA Fingerprinting; Drug Resistance, Bacterial; Enterococcus; Ethambutol; Feces; Humans; Korea; Lactobacillus; Microbial Sensitivity Tests; Molecular Sequence Data; Probiotics; Random Amplified Polymorphic DNA Technique; Rifampin; Staphylococcus aureus; Streptomycin; Time Factors; Vancomycin | 2005 |
Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
Topics: Amikacin; Anti-Bacterial Agents; Brazil; Ciprofloxacin; Clarithromycin; Clofazimine; Cycloserine; DNA Fingerprinting; DNA, Bacterial; Doxycycline; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Rifabutin; Rifampin; Streptomycin | 2005 |
Tularemia, a reemerging disease in northwest Turkey: epidemiological investigation and evaluation of treatment responses.
Topics: Adolescent; Adult; Aged; Agglutination Tests; Child; Ciprofloxacin; Disease Outbreaks; Doxycycline; Drug Therapy, Combination; Female; Francisella tularensis; Humans; Male; Middle Aged; Pharyngeal Diseases; Polymerase Chain Reaction; Streptomycin; Tularemia; Turkey | 2006 |
[E-test susceptibility results of brucella strains for streptomycin, rifampicin, ciprofloxacin and tetracycline].
Topics: Anti-Bacterial Agents; Brucella; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Rifampin; Streptomycin; Tetracycline | 2006 |
Error-prone DNA repair system in enteroaggregative Escherichia coli identified by subtractive hybridization.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Adhesion; Bile Acids and Salts; Biofilms; Ciprofloxacin; DNA Repair; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Molecular Sequence Data; Mutagenesis; Nucleic Acid Hybridization; Operon; Phenotype; Plasmids; Promoter Regions, Genetic; Streptomycin; Ultraviolet Rays; Virulence | 2007 |
Efficacy of prolonged antimicrobial chemotherapy for brucellar spondylodiscitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Brucella; Ciprofloxacin; Discitis; Doxycycline; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Rifampin; Streptomycin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Hypermutability in clinical isolates of Klebsiella pneumoniae is uncommon and is unrelated to ciprofloxacin resistance.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; London; Microbial Sensitivity Tests; Mutation; Rifampin; Streptomycin | 2010 |
Retrospective study of the rhinoscleroma about 14 cases in ENT departments of university hospitals (Côte d'Ivoire).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Combined Modality Therapy; Cote d'Ivoire; Developing Countries; Esthetics; Female; Hospitals, University; Humans; Male; Middle Aged; Retrospective Studies; Rhinoplasty; Rhinoscleroma; Streptomycin; Thiamphenicol; Tomography, X-Ray Computed; Young Adult | 2011 |
Antibiotic resistance and pathogenicity factors in Staphylococcus aureus isolated from mastitic Sahiwal cattle.
Topics: Adhesins, Bacterial; Animals; Bacterial Toxins; Cattle; Chloramphenicol; Ciprofloxacin; DNA, Ribosomal; Drug Resistance, Bacterial; Female; Gentamicins; Mastitis, Bovine; Methicillin-Resistant Staphylococcus aureus; Milk; Nucleic Acid Amplification Techniques; Oligonucleotides; Oxytetracycline; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Pristinamycin; Streptomycin; Virulence Factors | 2011 |
Electron microscopic study of the effects of antimicrobial agents on the cellular architecture of Leptospira.
Topics: Ampicillin; Anti-Infective Agents; Cell Membrane Permeability; Cell Shape; Ciprofloxacin; Leptospira; Microscopy, Electron, Transmission; Streptomycin | 2011 |
In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cell Line; Chloramphenicol; Ciprofloxacin; Doxycycline; Gentamicins; High-Throughput Screening Assays; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Plague; Streptomycin; Yersinia pestis | 2011 |
Treatment of inflammatory bowel disease associated E. coli with ciprofloxacin and E. coli Nissle in the streptomycin-treated mouse intestine.
Topics: Animals; Ciprofloxacin; Colony Count, Microbial; Drug Therapy, Combination; Escherichia coli; Female; Inflammatory Bowel Diseases; Intestines; Mice; Streptomycin | 2011 |
A simple and economical in-house phage technique for the rapid detection of rifampin, isoniazid, ethambutol, streptomycin, and ciprofloxacin drug resistance in Mycobacterium tuberculosis, directly on decontaminated sputum samples.
Topics: Adolescent; Adult; Aged; Antibiotics, Antitubercular; Ciprofloxacin; Ethambutol; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Mycobacteriophages; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant; Virus Replication; Young Adult | 2012 |
In-house, simple & economical phage technique for rapid detection of rifampicin, isoniazid, ethambutol, streptomycin & ciprofloxacin drug resistance using Mycobacterium tuberculosis isolates.
Topics: Antitubercular Agents; Bacteriophages; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Streptomycin; Tuberculosis, Multidrug-Resistant | 2012 |
Antimicrobial resistance profiles of Enterococcus faecalis and Enterococcus faecium isolated from artisanal food of animal origin in Argentina.
Topics: Animals; Anti-Bacterial Agents; Argentina; Bacterial Proteins; beta-Lactamases; Carbon-Oxygen Ligases; Cattle; Ciprofloxacin; Dairy Products; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Food Contamination; Food Microbiology; Genotype; Gentamicins; Goats; Meat Products; Microbial Sensitivity Tests; Penicillins; Phenotype; Streptomycin; Teicoplanin; Vancomycin | 2012 |
In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey.
Topics: Animals; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Ciprofloxacin; DNA Primers; Gentamicins; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Rifampin; Sheep; Sheep Diseases; Streptomycin; Sulfamethoxazole; Tetracycline; Trimethoprim; Turkey | 2013 |
High abundance and diversity of antimicrobial resistance determinants among early vancomycin-resistant Enterococcus faecium in Poland.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gentamicins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Poland; Streptomycin; Tetracycline; Vancomycin; Vancomycin Resistance | 2013 |
The ability of an antimicrobial agent to penetrate a biofilm is not correlated with its killing or removal efficiency.
Topics: Anti-Infective Agents; Bacillus cereus; Benzalkonium Compounds; Biofilms; Cell Culture Techniques; Cetrimonium; Cetrimonium Compounds; Ciprofloxacin; Disinfection; Pseudomonas fluorescens; Streptomycin | 2014 |
Protease-Sensitive Inhibitory Activity of Cell-free Supernatant of Lactobacillus crispatus 156 Synergizes with Ciprofloxacin, Moxifloxacin and Streptomycin Against Pseudomonas aeruginosa: An In Vitro Study.
Topics: Anti-Bacterial Agents; Chemical Phenomena; Ciprofloxacin; Culture Media, Conditioned; DNA, Bacterial; Drug Synergism; Female; Fluoroquinolones; Hot Temperature; Humans; Hydrogen-Ion Concentration; Lactobacillus; Microbial Sensitivity Tests; Moxifloxacin; Peptide Hydrolases; Pseudomonas aeruginosa; Sequence Analysis, DNA; Streptomycin; Urinary Tract Infections; Vagina | 2015 |
Pneumonic tularemia presenting with a vesicular eruption.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Female; Francisella tularensis; Humans; Pneumonia, Bacterial; Skin Diseases, Vesiculobullous; Streptomycin; Tularemia | 2015 |
Reduced Susceptibility to Rifampicin and Resistance to Multiple Antimicrobial Agents among Brucella abortus Isolates from Cattle in Brazil.
Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Brazil; Brucella abortus; Brucellosis; Cattle; Ciprofloxacin; DNA, Bacterial; Doxycycline; Drug Resistance, Multiple, Bacterial; Genotype; Gentamicins; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
Detection of antibiotic resistance in probiotics of dietary supplements.
Topics: Aztreonam; Bacteria; Ciprofloxacin; Dietary Supplements; Drug Resistance, Bacterial; Food Microbiology; Gentamicins; Lactobacillus; Pilot Projects; Probiotics; Streptomycin; Vancomycin | 2015 |
Protective role of E. coli outer membrane vesicles against antibiotics.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Colistin; Drug Resistance, Bacterial; Escherichia coli; Melitten; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Proteomics; Pseudomonas aeruginosa; Streptomycin; Trimethoprim | 2015 |
Design, Synthesis, and Characterization of Some Hybridized Pyrazolone Pharmacophore Analogs against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Drug Design; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Phosphotransferases (Alcohol Group Acceptor); Pyrazinamide; Pyrazolones; Schiff Bases; Streptomycin; Structure-Activity Relationship | 2016 |
Antimicrobial Potential of Thiodiketopiperazine Derivatives Produced by Phoma sp., an Endophyte of Glycyrrhiza glabra Linn.
Topics: Ampicillin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Drug Combinations; Endophytes; Glycyrrhiza; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Saccharomycetales; Staphylococcus aureus; Streptococcus pyogenes; Streptomycin; Xanthophylls | 2016 |
Biocide Tolerance and Antibiotic Resistance in Salmonella Isolates from Hen Eggshells.
Topics: Animals; Anti-Bacterial Agents; Benzalkonium Compounds; Ceftazidime; Chickens; Chloramphenicol; Ciprofloxacin; Disinfectants; Drug Resistance, Multiple, Bacterial; Egg Shell; Food Contamination; Food Microbiology; Microbial Sensitivity Tests; Nalidixic Acid; Salmonella; Salmonella enterica; Streptomycin; Tetracycline | 2017 |
Machine learning for classifying tuberculosis drug-resistance from DNA sequencing data.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Machine Learning; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Mixed pneumonic plague and nosocomial MDR-bacterial infection of lung: a rare case report.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Coinfection; Cross Infection; Drug Resistance, Multiple, Bacterial; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; Plague; Stenotrophomonas maltophilia; Streptomycin; Treatment Outcome; Yersinia pestis; Young Adult | 2018 |
Recovery of the Gut Microbiota after Antibiotics Depends on Host Diet, Community Context, and Environmental Reservoirs.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bacteroides; Biodiversity; Ciprofloxacin; Diet; Female; Gastrointestinal Microbiome; Gastrointestinal Tract; Germ-Free Life; Humans; Male; Mice; Rifaximin; Streptomycin | 2019 |
Clinical cases, drug resistance, and virulence genes profiling in Uropathogenic Escherichia coli.
Topics: Bacterial Toxins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Hemolysin Proteins; Humans; Membrane Proteins; Nalidixic Acid; Penicillins; Streptomycin; Tetracycline; Urinary Tract Infections; Uropathogenic Escherichia coli; Virulence; Virulence Factors | 2020 |
Klebsiella michiganensis transmission enhances resistance to Enterobacteriaceae gut invasion by nutrition competition.
Topics: Animals; Anti-Bacterial Agents; Bacteroidetes; Ciprofloxacin; Colony Count, Microbial; Dysbiosis; Escherichia coli; Firmicutes; Gastrointestinal Microbiome; Germ-Free Life; Klebsiella; Male; Mice; Mice, Inbred C57BL; Microbial Interactions; Salmonella typhimurium; Streptomycin; Symbiosis; Verrucomicrobia | 2020 |
Antibiotic resistance patterns and prevalence of class I, II and III Integrons among clinical isolates of Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Cefepime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Guidelines as Topic; Humans; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Male; Polymerase Chain Reaction; Pseudomonas aeruginosa; Streptomycin | 2020 |
Effect of resveratrol and quercetin on the susceptibility of Escherichia coli to antibiotics.
Topics: Anti-Bacterial Agents; Antioxidants; beta-Galactosidase; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Kanamycin; Oxidative Stress; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Streptomycin; Stress, Physiological | 2020 |
Clinically relevant mutations in core metabolic genes confer antibiotic resistance.
Topics: Adaptation, Physiological; Anti-Bacterial Agents; Carbenicillin; Ciprofloxacin; Citric Acid Cycle; Directed Molecular Evolution; Drug Resistance, Bacterial; Energy Metabolism; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Knockdown Techniques; Genes, Bacterial; Genome, Bacterial; Ketoglutarate Dehydrogenase Complex; Microbial Sensitivity Tests; Mutation; Sequence Analysis, DNA; Streptomycin | 2021 |
Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains.
Topics: Antitubercular Agents; Ciprofloxacin; Disease Progression; Drug Carriers; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Streptomycin; Structure-Activity Relationship; Thiophenes; Toll-Like Receptors | 2021 |
Prevalence and antimicrobial susceptibility of Enterococcus spp. from urine of dogs and cats in northwestern Croatia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cat Diseases; Cats; Chloramphenicol; Ciprofloxacin; Croatia; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins; Prevalence; Rifampin; Streptomycin; Tetracycline; Vancomycin | 2022 |
Pathogenicity and transcriptome analysis of a strain of Vibrio owensii in Fenneropenaeus merguiensis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Ciprofloxacin; Citrates; Gene Expression Profiling; Immunity, Innate; Lectins, C-Type; Minocycline; Oxacillin; Penaeidae; Phosphatidylinositol 3-Kinases; Piperacillin; Proto-Oncogene Proteins c-akt; Pyruvates; Streptomycin; Transcriptome; Vibrio; Virulence | 2022 |
Characterization and Transferability of erm and tet Antibiotic Resistance Genes in Lactobacillus spp. Isolated from Traditional Fermented Milk.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Lactobacillus; Microbial Sensitivity Tests; Milk; RNA, Ribosomal, 16S; Sodium Chloride; Streptomycin; Trimethoprim; Vancomycin | 2022 |
Analysis of the Antimicrobial and Anti-Biofilm Activity of Natural Compounds and Their Analogues against
Topics: Aldehydes; Amikacin; Ampicillin; Anti-Bacterial Agents; Biofilms; Cephalothin; Chloramphenicol; Ciprofloxacin; Clindamycin; Eugenol; Gentamicins; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Streptomycin | 2022 |
Comparison of disk diffusion and broth microdilution methods for antimicrobial susceptibility testing of Campylobacter isolates of meat origin.
Topics: Anti-Bacterial Agents; Campylobacter; Ciprofloxacin; Erythromycin; Gentamicins; Meat; Microbial Sensitivity Tests; Nalidixic Acid; Streptomycin; Tetracycline | 2023 |
High prevalence of intermediate resistance to ciprofloxacin in Salmonella enterica isolated from a Brazilian poultry production chain, located in Minas Gerais state.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Brazil; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Poultry; Prevalence; Salmonella enterica; Streptomycin | 2023 |